FDA's greenlighting of maternal RSV vaccine represents a major step forward in protecting young babies against the virus

By Annette Regan, Associate Professor of Epidemiology, University of San Francisco
Flor M. Munoz, Associate Professor of Pediatric Infectious Diseases, Baylor College of Medicine

With the Food and Drug Administration’s Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have a major new tool at its disposal to protect infants against the highly contagious virus.

RSV is the most common cause of lower respiratory infections in young children…

Read complete article

~	Supreme Court’s decision on birthright citizenship will depend on its interpretation of one key phrase

~	Frank Gehry, the architect of the unconventional, the accidental, and the inspiring, has died at 96

~	Hong Kong’s Sham Elections Expose Beijing’s Tightening Grip

~	What our missing ocean float revealed about Antartica’s melting glaciers

~	Sweden’s mining industry is threatening the Indigenous Sami people’s way of life

~	The world is facing a cancer crisis that’s hitting the most vulnerable hardest

~	The Supreme Court’s decision on birthright citizenship will depend on its interpretation of one phrase

~	Syria: Effort to buttress human rights since Assad’s fall, ‘only the beginning of what needs to be done’

~	Burkina Faso: Plans to reinstate death penalty must be stopped

~	Russia: Authorities step up criminal reprisals against anti-war Yabloko party